COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus

This review describes the incidence, epidemiology, and risk factors for mortality of COVID-19 in immunocompromised patients, including persons with human immunodeficiency virus. It describes various preventive measures, including vaccines and their effectiveness and the role of monoclonal antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakharia, Niyati, Subramanian, Aruna K., Shapiro, Adrienne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806148/
https://www.ncbi.nlm.nih.gov/pubmed/35636907
http://dx.doi.org/10.1016/j.idc.2022.01.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806148/
https://www.ncbi.nlm.nih.gov/pubmed/35636907
http://dx.doi.org/10.1016/j.idc.2022.01.006

Ejemplares similares